Wordt geladen...
Bcl-2/Bcl-xL inhibitor ABT-263 overcomes hypoxia-driven radioresistence and improves radiotherapy
Hypoxia, a characteristic of most human solid tumors, is a major obstacle to successful radiotherapy. While moderate acute hypoxia increases cell survival, chronic cycling hypoxia triggers adaptation processes, leading to the clonal selection of hypoxia-tolerant, apoptosis-resistant cancer cells. Ou...
Bewaard in:
| Gepubliceerd in: | Cell Death Dis |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Nature Publishing Group UK
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8277842/ https://ncbi.nlm.nih.gov/pubmed/34257274 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-021-03971-7 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|